Abstract
Objective
Invasive aspergillosis is associated with a poor prognosis, especially in critically ill patients with cerebral involvement. We present two cases of cerebral invasive aspergillosis successfully treated in the intensive care unit with combination antifungal therapies and without surgery.
Case presentation
The first patient was a 49-year-old man with rheumatoid arthritis who received corticosteroid and cyclophosphamide treatment and developed pulmonary and cerebral invasive aspergillosis. After failure of voriconazole the patient had a successful outcome with voriconazole and liposomal amphotericin B therapy. The patient returned home after an 8-month hospital stay. The second patient was a 54-year-old woman with pulmonary neoplasia and corticosteroid treatment who developed pulmonary and cerebral invasive aspergillosis. After failure of voriconazole and liposomal amphotericin B therapy the patient had a favorable outcome with liposomal amphotericin B and caspofungin therapy. The patient died 10 months after initial diagnosis of cardiac tamponade unrelated to fungal infection.
Discussions
These cases illustrate the improving prognosis of invasive aspergillosis due to the availability of new treatments, especially in cases of cerebral involvement. It also demonstrates that the outcome of critically ill patients requiring mechanical ventilation for invasive aspergillosis can be favorable. The treatment of patients with invasive cerebral aspergillosis in the intensive care setting should be encouraged.
References
Steinbach WJ, Stevens DA, Denning DW (2003) Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clin Infect Dis 37 [Suppl 3]:S188–S224
Schwartz S, Thiel E (2004) Update on the treatment of cerebral aspergillosis. Ann Hematol 83 [Suppl 1]:S42–S44
Vandewoude KH, Blot SI, Benoit D, Colardyn F, Vogelaers D (2004) Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J Hosp Infect 56:269–276
Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E (2004) Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 170:621–625
Guermazi A, Gluckman E, Tabti B, Miaux Y (2003) Invasive central nervous system aspergillosis in bone marrow transplantation recipients: an overview. Eur Radiol 13:377–388
Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A, Ruhnke M, Lode H (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34:563–571
Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415
Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB, Sable CA, Kartsonis NA, Ngai A, Taylor A, Patterson TF, Denning DW, Walsh TJ, Caspofungin Salvage Aspergillosis Study Group (2004) Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 39:1563–1571
Damaj G, Ivanov V, Le Brigand B, D’Incan E, Doglio MF, Bilger K, Faucher C, Vey N, Gastaut JA (2004) Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient. Ann Hematol 83:390–393
Schwartz S, Milatovic D, Thiel E (1997) Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol 97:663–665
Lastours V de, Lefort A, Zappa M, Dufour V, Belmatoug N, Fantin B (2003) Two cases of cerebral aspergillosis successfully treated with voriconazole. Eur J Clin Microbiol Infect Dis 22:297–299
Marbello L, Nosari A, Carrafiello G, Anghilieri M, Cesana C, Cafro AM, D’Avanzo G, Morra E (2003) Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient. Haematologica 88:ECR05
Vandewoude K, Vogelaers D, Decruyenaere J, Jaqmin P, De Beule K, Van Peer A, Woestenborghs R, Groen K, Colardyn F (1997) Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units. Antimicrob Agents Chemother 41:2714–2718
Sanchez C, Mauri E, Dalmau D, Quintana S, Aparicio A, Garau J (1995) Treatment of cerebral aspergillosis with itraconazole: do high doses improve the prognosis? Clin Infect Dis 21:1485–1487
Groll AH, Giri N, Petraitis V, Petraitiene R, Candelario M, Bacher JS, Piscitelli SC, Walsh TJ (2000) Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 182:274–282
Baslar Z, Soysal T, Hanci M, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B (1998) Successfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient. Bone Marrow Transplant 22:404–405
Baslar Z, Soysal T, Hanci M, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B (1997) Successful outcome of aspergillus brain abscess in a patient who underwent bone marrow transplantation for aplastic anemia. Haematologia (Budap) 28:265–271
Iemmolo RM, Rossanese A, Rotilio A, Mattisi G, Gerunda GE, Merenda R, Neri D, Crepaldi G, Strazzabosco M (1998) Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery. J Hepatol 28:518–522
Roy V, Ali LI, Carter TH, Selby GB (2000) Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease. J Infect 41:273–275
Carlini A, Angelini D, Burrows L, De Quirico G, Antonelli A (1998) Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant. Nephrol Dial Transplant 13:2659–2661
Acknowledgements
The authors thank Miss Andrea Pritzker for review of the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ehrmann, S., Bastides, F., Gissot, V. et al. Cerebral aspergillosis in the critically ill: two cases of successful medical treatment. Intensive Care Med 31, 738–742 (2005). https://doi.org/10.1007/s00134-005-2605-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-005-2605-5